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ABSTRACT
MafB proteins are toxins secreted by Neisseria spp. which are involved in interbacterial competition. 
Their secretion mechanism has so far not been elucidated. Each strain can produce several MafB 
variants. On the chromosome, the mafB genes are localized on genomic islands also containing mafA 
genes. MafA proteins have a role in virulence with reported activities in adhesion and transcytosis of 
pathogenic Neisseria, a priori unrelated to MafB activities. In this study, we investigated the possible 
involvement of MafA in the transport of MafB across the outer membrane of Neisseria meningitidis. In 
wild-type strains, proteolytic fragments of MafB proteins were detected in the extracellular medium. In 
the absence of MafA, secretion was abrogated, and, in the case of MafBI, full-length and truncated 
polypeptides were detected inside the cells and inside outer-membrane vesicles. MafBI secretion 
required its cognate MafA, whereas MafBIII could use any MafA. Heterologous expression in 
Escherichia coli showed that MafBIII is transported to a cell-surface-exposed, i.e. protease-accessible, 
location in a MafA-dependent way. MafA itself was found to be localized to the outer membrane, 
forming large oligomeric complexes. As homologs were found in diverse bacteria, the Maf system 
represents a new protein secretion system in Gram-negative bacteria.
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Proteins produced by Gram-negative bacteria and 
destined to the extracellular milieu must be translo-
cated across a cell envelope composed of two mem-
branes, the inner membrane (IM) and the outer 
membrane (OM), which are separated by the peri-
plasm containing a peptidoglycan layer. Various 
protein secretion systems, dubbed type I to VI, 
have evolved in these bacteria [1]. Secretion via the 
type V system occurs in two steps. Proteins first 
cross the IM using the Sec machinery. 
Subsequently, they cross the OM via a specific 
transporter, which can be an independent protein 
or be part of the secreted protein in the cases of 
two-partner secretion (TPS) systems [2] and auto-
transporters [3], respectively. In both cases, the 
transporter is integrated into the OM by the β- 
barrel assembly machinery (BAM), a complex of 
several proteins that orchestrates the folding and 
insertion of new OM proteins [4]. In the TPS sys-
tem, the secreted protein and the transporter are 
generically called TpsA and TpsB, respectively. 
TpsB is a homolog of BamA, the central component 
of the BAM. It consists of a 16-stranded OM- 
embedded β-barrel and two periplasmically exposed 
polypeptide transport-associated (POTRA) domains 
[2]. TpsA interacts with TpsB via its N-terminally 
located TPS domain, which is recognized by the 
POTRA domains of the TpsB [2]. In several micro-
organisms, TPS systems are involved in interbacter-
ial competition by inhibiting the growth of related 
bacteria. In such cases, they are also referred to as 
CDI (contact-dependent growth-inhibition) systems 
[5]. The TpsA (or CdiA) proteins of these systems 
are very large β-helical protein of >2000 amino-acid 
residues that display a small toxic domain at the 
C terminus. In the proposed model [6], surface- 
exposed TpsA interacts with a receptor on the target 
cells, e.g. BamA or another OM protein [5], after 
which the toxic domain of TpsA is cleaved and 
transported into the cytosol of the target cell, 
where it exerts one of various toxic activities. 
A small protein encoded by a gene called tpsI, 
which is located immediately downstream of the 
tpsA gene, protects the producing cells against the 
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toxic C-terminal domain of TpsA; thereby, the 
C-terminal domain of TpsA and TpsI constitute 
together a toxin/antitoxin module [5].
Neisseria meningitidis is a commensal inhabitant of 
the upper respiratory tract of humans, but occasionally, 
it can reach the blood stream and cross the blood-brain 
barrier to cause sepsis and/or meningitis. The type 
V secretion system (T5SS) constitutes the main secre-
tion pathway in N. meningitidis, where it encompasses 
up to eight different autotransporters and, dependent 
on the specific strain, one or several TPS systems [7]. 
The TPS systems are involved in CDI [8], besides 
additional functions in biofilm formation and patho-
genesis [9]. The genes for the TPS systems are often 
localized on genomic islands, which usually also con-
tain a repertoire of tpsC cassettes. These cassettes puta-
tively encode N-terminally truncated TpsA proteins 
with sequences for different toxic domains and are 
associated with genes encoding the corresponding 
immunity proteins. They can recombine with the tpsA 
locus, thereby replacing the toxic domain of the TpsA 
protein [8].
Blast searches using different toxic domains of TpsA 
proteins as queries identified a novel growth-inhibition 
system in Neisseria spp., the MafB proteins [10,11]. 
Apart from the presence of the toxic domain, MafB 
proteins do not show any similarity with TpsA pro-
teins. They consist of an N-terminal signal sequence, 
a conserved domain of unknown function, i.e. 
DUF1020, and a C-terminal toxic domain. In some 
MafB proteins, a Hint domain, which is expected to 
mediate protein self-splicing [12,13] separates the 
DUF1020 from the toxic domain. The mafB genes are 
localized on the chromosome in genomic islands desig-
nated Maf Genomic Islands (MGI). Up to three MGI 
can be present in a single meningococcal strain (Figure 
1) [11]. Based on phylogenetic analysis of the DUF1020 
domain, three classes of MafB can be distinguished, 
designated MafBI-MafBIII (Figure 1), where classes 
I and II MafB proteins are more closely related to 
each other than to MafBIII [10]. Within the MGI, the 
mafB genes are flanked by a mafI gene, which encodes 
an immunity protein that protects the producing cells 
against the toxic activity of MafB [10,11], and, usually, 
a mafA gene (Figure 1). Phylogenetic analysis distin-
guished two classes of MafA proteins, MafAI and 
MafAII [10], where mafBI and mafBIII genes are always 
associated with mafAI and mafAII genes, respectively. 
The mafBII genes are not directly adjacent to a mafA 
gene, but they are localized on an MGI also containing 
a mafBI and a mafAI (Figure 1). In addition, each MGI 
contains a variable repertoire of genes putatively encod-
ing N-terminally truncated MafB proteins with variable 
toxic domains and cognate immunity proteins (Figure 
1), an organization resembling the tpsC cassettes in the 
TPS islands.
The secretion mechanism of MafB has not been 
elucidated so far. MafA would be an obvious candidate 
Figure 1. Organization of the MGI of N. meningitidis strain B16B6. Strain B16B6 has three MGI [10]. Genes flanking the islands are 
indicated with filled black arrows. Filled colored arrows indicate mafA and mafB genes; their proposed systematic names [11] and the 
phylogenetic classes of the encoded proteins [10] are given above and below the arrows, respectively. Color coding: orange, MafAI; 
blue, MafAII; garnet, MafBI; pink, MafBII; green, MafBIII. Open colored arrows downstream of the mafB genes refer to truncated mafB 
genes that lack regular 5 sequences. Their color refers to high sequence similarity with the upstream intact mafB, although their 3
end, encoding the toxic domain, is entirely different. MGI-3 contains an additional complete mafB gene, but it is disrupted by 
a frameshift mutation (indicated with red slash). Open black arrows represent small open reading frames, including mafI genes 
encoding immunity proteins. Where multiple small open reading frames are located downstream of a mafB or truncated mafB, it is 
not always clear which one encodes the corresponding immunity protein. Lines numbered a-d refer to the polypeptides that were 
produced to raise antisera.
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for a protein involved in the secretion process, but such 
a role could not be demonstrated [11]. MafA is pro-
duced with a signal sequence typical of lipoproteins 
(Figure S1A). The protein does not show any similarity 
with TpsB and, in fact, secondary structure predictions 
do not suggest a β-barrel structure, which is typical for 
integral OM proteins, at all (Figure S1A). Previously, 
MafA proteins have been reported to function as adhe-
sins that bind host glycolipids [14] (hence the notation 
Maf, which stands for meningococcal adhesin family). 
Recently, Káňová et al (2019) showed that meningo-
coccal MafAI protein binds to human brain microvas-
cular endothelial cells (hBMEC) [15], evidencing that 
the protein participates in the adhesion of the menin-
gococcus to eukaryotic cells. Moreover, transcriptome 
analysis of hBMEC stimulated with MafA protein 
revealed that the hBMEC responsed by regulating 
a large number of genes participating in a variety of 
biological processes related to bacterial transcytosis 
[16], including cell surface modifications, endocytosis, 
extracellular matrix reorganization, and proinflamma-
tory cytokine production, among others. Thus, 
reported evidences suggest an important role of MafA 
in the virulence of pathogenic Neisseria spp. 
Nevertheless, we decided to explore further the possi-
bility that MafA is the dedicated transporter of MafB, 
and the results are presented here.
Material and methods
Bioinformatics
Amino-acid sequences encoded by mafA and mafB 
genes were predicted using clone Manager Suite 7. 
The cleavage site of the N-terminal signal sequence of 
MafB proteins was predicted using (http://www.cbs.dtu. 
dk/services/SignalP/) and the lipobox of MafA proteins 
using (http://www.cbs.dtu.dk/services/LipoP/). Protein 
sequences were aligned in MAFFT version 7 (http:// 
align.bmr.kyushu-u.ac.jp/mafft/online/server/). For sec-
ondary structure predictions PsiPred [17] was used. For 
helical wheel projections HELIQUEST was used (http:// 
heliquest.ipmc.cnrs.fr).
Bacterial strains and growth conditions
All strains used in this study are listed in Table 1. 
N. meningitidis strain BB-1 is an unencapsulated deri-
vative of B16B6 [18]. Meningococcal strains were 
grown overnight on GC medium base (Difco) supple-
mented with IsovitaleX (Becton Dickinson) at 37°C in 
a candle jar. To grow the bacteria in liquid cultures, 
bacteria were collected from GC plates and diluted in 
tryptic soy broth (Beckton Dickinson) to an optical 
density at 550 nm (OD550) of 0.15 and incubated in 25- 
cm2 polystyrene cell culture flasks or 125-ml square 
media bottles with constant shaking at 110 r.p.m. for 
6 h to an OD550 of ~2. Escherichia coli strains DH5α 
and BL21(DE3) were used for cloning and protein 
production, respectively, and they were grown in lyso-
geny broth (LB) while shaking at 200 r.p.m. at 37°C or 
on LB plates.
For plasmid maintenance, the culture medium was 
supplemented where appropriate with antibiotics in the 
following concentrations: 7 μg ml−1 chloramphenicol 
(Sigma-Aldrich), 7 μg ml−1 erythromycin (Fluka 
Analytical), 100 μg ml−1 kanamycin (Sigma-Aldrich), 
or 60 μg ml−1 gentamicin (Sigma-Aldrich) for 
N. meningitidis, and 25 μg ml−1 chloramphenicol, 
150 μg ml−1 erythromycin, 100 μg ml−1 kanamycin, or 
20 μg ml−1 gentamicin for E. coli. To induce gene 
expression, 0.1 mM isopropyl-β- 
D-1-thiogalactopyranoside (IPTG) (Thermo Scientific) 
was added at the start of the liquid cultures.
DNA constructs
DNA fragments were amplified by PCR from chromo-
somal DNA of N. meningitidis strains BB-1 and FAM18 
with primers listed in Supplementary Table S1 using 
High Fidelity Polymerase (Roche Diagnostics GmbH, 
Germany) or DreamTaq-DNA Polymerase (Fermentas, 
UK). PCR products were visualized in 1% agarose gels 
with ethidium bromide. Plasmids used in this study are 
listed in Table 1. For cloning, PCR products and vec-
tors were purified using the Clean-Up System and 
Plasmid Extraction kit, respectively (both from 
Promega). Purified vectors and PCR products were 
digested with the restriction enzymes (Fermentas) for 
which sites were included in the primers (Table S1) and 
subsequently ligated together. E. coli DH5α was trans-
formed with ligation products, and transformants were 
selected on LB- agar plates supplemented with appro-
priate antibiotics. Correct clones were elected by PCR, 
and plasmids were purified and sequenced at the 
Macrogen sequencing service (Amsterdam). Then, plas-
mids were transferred by transformation to E. coli BL21 
(DE3) or to N. meningitidis strains. For E. coli, 5 μl of 
plasmid was added to competent cells suspended in LB 
medium supplemented with 85 mM of CaCl2 and 15% 
of glycerol (v/v), incubated 15 min on ice, and the 
bacterial suspension was placed during 30 seconds at 
42ºC, and immediate after incubated on ice during 5 
min. Then, bacterial cells were resuspended in LB med-
ium and incubated at 37ºC at 200 r.p.m during 1 h. 
Finally, cells were harvested by centrifugation and 
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spread onto agar plates supplemented with appro-
priated antibiotics. For N. meningitidis, an overnight 
colony was picked up and streak onto a small area 
(~2 cm2) of a GC-agar plate, and 15 μl of purified 
plasmid in 10 mM of MgCl2 was dropped on top of 
the culture and allowed to air-dry at room temperature. 
After 8 h of incubation at 37ºC, the colony was spread 
onto an GC-agar plate supplemented with appropriated 
antibiotics.
To generate constructs for antiserum production, 
DNA fragments corresponding to amino-acid residues 
16–313 of MafAI, 21–320 of MafAII, 28–239 of MafBI.1, 
and 26–239 of MafBIII (fragments a-d in Figure 1) were 
amplified from BB-1. These fragments are missing the 
sequences encoding the signal sequences and, for the 
MafB proteins, the C-terminal toxic domains. They 
were cloned into pET16b, thereby generating an 
N-terminal His-tag in the produced proteins. The 
resulting plasmids were called pET-MafAI-H, pET- 
MafAII-H, pET-MafBI-H and pET-MafBIII-H, 
respectively. To generate plasmids for the synthesis of 
MafBIII and MafI from MGI-3 either with or without 
the cognate MafAII in E. coli, PCR fragments were 
cloned into pINL, a derivative of pCRII-TOPO carrying 
a modified opaB promoter [19]. The resulting plasmids 
are called pIN-AII-BIII-I and pIN-BIII-I, respectively. To 
produce recombinant MafBI (NMC1790) of FAM18 
and MafBIII of BB-1 in N. meningitidis, PCR products 
containing the mafB genes without the sequences cor-
responding to the toxic domain were cloned into plas-
mid pFPIORF1 [8]. Sequences for a Strep- or a 10xHis- 
tag were incorporated in the reverse primers (Table S1). 
The corresponding plasmids were called pEN-mafBI-S, 
pEN-mafBI-H and pEN-mafBIII-S, where the affixes 
S and H refer to the presence of a Strep- or a His-tag, 
respectively. The mafA genes from MGI-1 and MGI-3 
were amplified from BB-1 with sequences for a 6xHis- 
tag sequence included in the reverse primer and cloned 
into pFPIORF1. The resulting constructs were called 
pEN-mafAI-H and pEN-mafAII-H, respectively. The 
Table 1. Bacterial strains and plasmids used in this study.
Strains or plasmids Descriptiona Referenceb
Strains
E. coli
DH5α F−, Δ(lacZYA-argF)U169 thi-1 hsdR17 gyrA96 recA1 endA1 supE44 relA1 phoA Φ80dlacZΔM15 UU
BL21(DE3) N. meningitidis Contains gene for T7 DNA polymerase Invitrogen
FAM18 Wild type, C:2a, cc11
B16B6 Wild type, B:2a, cc11
BB-1 B16B6 with the capsule locus replaced by ery [18]
BB-1 ΔmafAI.1 BB-1 with mafAMGI-1 replaced by kan [10]
BB-1 ΔmafAI.2 BB-1 with mafAMGI-2 replaced by kan [10]
BB-1 ΔmafAII BB-1 with mafAMGI-3 replaced by kan [10]
BB-1 ΔmafBI.1 BB-1 with mafB and downstream cassettes of MGI-1 replaced by kan [10]
BB-1 ΔmafBI.2 BB-1 with mafB2 and downstream cassettes of MGI-2 replaced by kan [10]
BB-1 ΔmafBI.1 ΔmafBI.2 BB-1 with mafB and mafB2 and downstream cassettes replaced by kan and cat, respectively This study
BB-1 ΔnalP BB-1 with nalP replaced by kan [18]
BB-1 Δiga BB-1 with iga replaced kan [18]
BB-1 Δapp BB-1 with app replaced by kan [18]
BB-1 ΔmafAI.1 ΔmafAI.2 BB-1 with mafAMGI-1 and mafAMGI-2 replaced by kan and cat, respectively This study
B16B6ΔmafAI.1 ΔmafAI.2 ΔmafAII B16B6 with mafAMGI-1, mafAMGI-2 and mafAMGI-3 replaced by kan, cat and gm, 
respectively
This study
B16B6 ΔmafAI.1 ΔmafAI.2 B16B6 with mafAMGI-1 and mafAMGI-2 replaced by kan and cat, respectively This study
Plasmids
pET16b T7 promoter, 5‘ His-tag sequence in frame, lacI, amp Invitrogen
pET-MafAI-H pET16b plasmid containing partial mafAMGI-1 gene of BB-1. amp This study
pET-MafAII-H pET16b plasmid containing partial mafAMGI-3 gene of BB-1. amp This study
pET-MafBI-H pET16b plasmid containing partial mafBMGI-1 gene of BB-1. amp This study
pET-MafBIII-H pET16b plasmid containing partial mafB1MGI-3 gene of BB-1. amp This study
pINL phrtA-gm-gfp containing a constitutive opaBPL promoter. gm, kan, amp [19]
pIN-AII-BIII-I Derivative of pINL containing mafAII, mafBIII and mafI of BB-1. amp, kan, gm This study
pIN-BIII-I Derivative of pINL containing mafBIII and mafI of BB-1. amp, kan, gm This study
pFPIORF1 pEN plasmid containing IORF1 gene of BB-1. ery, cat [8]
pEN-mafBI-H pEN plasmid containing partial mafBI.1 gene of FAM18 with His tag sequence. ery, cat This study
pEN-mafBI-S pEN plasmid containing partial mafBI.1 gene of FAM18 with Strep tag sequence. ery, ca This study
pEN-mafBIII-S pEN plasmid containing partial mafBIII gene of BB-1 with strep tag sequence. ery, cat This study
pEN-mafAI-H pEN plasmid containing mafAI.1 gene of BB-1 with His tag sequence. ery, cat This study
pEN-mafAII-H pEN plasmid containing mafAII gene of BB-1 with His tag sequence. ery, cat This study
pKOmafAMGI-2::kan mafAI.2 knockout construct. amp, kan [10]
pKOmafAMGI-3::kan mafAII knockout construct. amp, kan [10]
pKOmafAMGI-2::cat pKOmafAMGI-2::kan derivative with kan replaced by cat. amp, cat This study
pKOmafAMGI-3::gm pKOmafAMGI-3::kan derivative with kan replaced by gm. amp, gm This study
pKOnhbA-cat nhbA knockout construct. amp, cat [18]
akan, kanamycin-resistance cassette; amp, ampicillin-resistance cassette; gm, gentamicin-resistance cassette; cat, chloramphenicol-resistance cassette; ery, 
erythromycin-resistance cassette; cc, clonal complex. bUU, Utrecht University laboratory collection. 
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synthesis of all recombinant proteins was detected by 
Western blotting.
For the construction of double and triple mafA 
mutants, the kanamycin-resistance cassettes of the 
mafAMGI-2 and mafAMGI-3 knockout constructs [10] 
were replaced by a chloramphenicol-resistance cassette 
from pKOnhbA-cat [8] and a gentamicin-resistance 
cassette amplified by PCR from pINL [19], respectively, 
via SalI digestion.
Cell fractionation, SDS-PAGE and Western blotting
N. meningitidis and E. coli strains were grown to an 
OD550 of 2 and an OD600 of 1, respectively. The cul-
tures were centrifuged (4,500 g for 5 min), and the 
resulting cell pellet was resuspended in H2O to a final 
OD550 of 10. The spent media were centrifuged at 
16,000 g for 15 min to remove residual cells, and 
proteins were precipitated from the supernatants with 
10% (w/v) ice-cold trichloroacetic acid (TCA) in H2 
O. For SDS-PAGE and Western-blot analysis, super-
natant samples were 50-fold concentrated relative to 
the cell samples. OM vesicles (OMVs) were removed 
from spent medium fractions by ultracentrifugation at 
100,000 g for 2 h, and proteins were precipitated from 
the resulting supernatant with TCA as above. The 
OMVs were resuspended in H2O in the same volume 
as that of the supernatant fraction. For cell envelope 
isolation, bacteria cells from 6-h old growth cultures, 
were harvested by centrifugation and resuspended in 50 
mM Tris-HCL with 5 mM EDTA (pH 8.0) and stored 
overnight at −20ºC. Cells were disrupted by sonication 
with a Branson sonifier 450 (Brason Ultrasonics 
Corporation) three times during 45 s (level 8, output 
40%). Unbroken cells were first removed by centrifuga-
tion (12,000 g for 30 min at 4ºC). Cell envelopes, pre-
sent in the supernatant, were collected by 
ultracentrifugation (170,000 × g for 30 min at 4°C), 
resuspended in 2 mM Tris-HCl (pH 7.6), and stored 
at −20°C. Protein concentrations in cell envelope pre-
parations were determined with the BCA assay kit 
(Thermo Fisher Scientific). SDS-PAGE was performed 
on 8, 12 or 14% polyacrylamide gels in a discontinuous 
buffer system. Before loading, samples were mixed 1:1 
with double-strength sample buffer [0.125 M Tris-HCl, 
pH 6.8, 20% (v/v) glycerol, 4% (w/v) SDS, 0.02% bro-
mophenol blue, 5% (v/v) β-mercaptoethanol] and 
heated for 10 min at 100°C. For semi-native SDS- 
PAGE, the sample buffer contained only 0.2% SDS 
(final concentration) and no β-mercaptoethanol, and 
the samples were kept at room temperature before 
electrophoresis [20]. Electrophoresis was carried out at 
200 V for ~45 min at room temperature or at 12 mA 
for ~180 min on ice for semi-native SDS-PAGE. 
Proteins separated on gels were stained with 
Coomassie brilliant blue G250 or transferred to nitro-
cellulose membranes, and the Western blots were 
developed as previously described [18]. The monoclo-
nal antibody MN2D6D directed against RmpM was 
generously provided by the Netherlands Vaccine 
Institute (Bilthoven, The Netherlands), and the DsbA1 
antiserum was previously described [21]. Monoclonal 
anti-His (Sigma Aldrich) and anti-Strep (Novagen) 
antibodies were also used. The antisera directed against 
the α-peptide and the translocator domain of IgA pro-
tease [22] and monoclonal antibody 2CE directed 
against OmpA were from our laboratory collection.
Purification of recombinant Maf proteins and 
antiserum production
MafA and fragments of MafB proteins of strain BB-1 
were produced and purified as described [18]. Briefly, 
the recombinant polypeptides with an N-terminal His- 
tag were produced from plasmids pET-MafAI-H, pET- 
MafAII-H, pET-MafBI-H, and pET-MafBIII-H in E. coli 
BL21(DE3) after induction with IPTG and purified as 
inclusion bodies. The protein bands corresponding to 
the recombinant proteins were excised from SDS- 
PAGE gels and eluted, and the protein concentration 
was determined with the BCA assay kit. Purified pro-
teins were used to raise antisera in mice at Eurogentec 
(Liège, Belgium).
Protein identification
For MALDI-TOF peptide map fingerprinting analysis, 
cell envelopes of BB-1 overproducing MafAII from 
plasmid pEN-mafAII-H and, as a control, of its deriva-
tive B16B6 ΔmafAI.1 ΔmafAI.2 ΔmafAII lacking all mafA 
genes were used. Proteins were separated by semi- 
native SDS-PAGE and individual bands, from the posi-
tion corresponding to that of MafAII in the overprodu-
cing strain as detected on Western blot, were cut from 
Coomassie brilliant blue G250-stained gels. The excised 
bands from both samples were sent to the Section of 
Proteomics (SCSIE) of the Universidad de Valencia 
(Spain) for protein identification. Samples were 
digested with sequencing grade trypsin (Promega) as 
described [23]. The digestion mixtures were dried, 
resuspended in 7 ml of 0.1% trifluoroacetic acid 
(TFA), and 1 ml was spotted on a MALDI plate. After 
the droplets were air-dried at room temperature, 1 μl of 
matrix [5 mg/ml CHCA (Sigma) in 0.1% TFA- 
acetonitrile/H2O (1:1, v/v)] was added and allowed to 
air-dry at room temperature. The resulting mixtures 
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were analyzed in a 5800 MALDI TOF/TOF (ABSciex) 
in positive reflectron mode (3000 shots every position). 
Five of the most intense precursors (according to the 
threshold criteria: minimum signal-to-noise: 10; mini-
mum cluster area: 500; maximum precursor gap: 200 
ppm; maximum fraction gap: 4) were selected for every 
position for the MS/MS analysis. MS/MS data was 
acquired using the default 1kV MS/MS method. The 
MS and MS/MS information was sent to MASCOT 
version 2.3.02 via the Protein Pilot version 4.5 
(ABSciex). Significant protein scores greater than 83 
(P < 0.05) were considered.
Proteinase K accessibility assays
Proteinase K accessibility of proteins in intact cells was 
assessed as described [20] with some modifications. 
Briefly, N. meningitidis and E. coli from cultures 
grown to an OD550 of 2.0 or an OD600 of 0.5, respec-
tively, were adjusted to an OD550 of 1 or an OD600 of 5, 
respectively, and incubated with proteinase 
K (Fermentas) for 1 h at 37°C. The protease was inac-
tivated with 2 mM phenylmethylsulfonyl fluoride 
(Sigma-Aldrich) for 20 min at room temperature, and 
cells were harvested by centrifugation. Protease acces-
sibility of proteins in OMV-containing supernatant 
fractions was assessed by incubating these fractions 
for 1 h with proteinase K, and protease-resistant pro-
teins were subsequently precipitated with TCA as 
described above. Protein degradation was examined 
by SDS-PAGE and Western blotting.
Separation of OM and IM
OM and IM of N. meningitidis were separated by 
sucrose density gradient centrifugation as described 
[21] with modifications. Bacteria from liquid cultures 
grown to an OD550 of 1 were inactivated with 1 mg 
ml−1 of streptomycin for 1 h, harvested by centrifuga-
tion (4,500 g for 20 min at 4°C), washed in 50 mM 
Tris-HCl, 5 mM EDTA pH 7.4 (TE), and resuspended 
in TE buffer with 15% (w/v) sucrose supplemented with 
50 μg ml−1 of DNase I and RNase A, 0.5 mg ml−1 of 
lysozyme, and 150 mM DL-dithiothreitol (DTT) (all 
from Sigma-Aldrich). Cells were disrupted in a French 
pressure cell at 1.5 × 105 kPa. Residual cells were 
removed by centrifugation (4,000 g for 30 min at 4° 
C), and supernatant was ultracentrifuged (100,000 g for 
90 min at 4°C) to pellet the cell envelopes, which were 
resuspended in TE buffer with 15% (w/v) sucrose and 
2 mM DTT. This suspension was loaded on top of 
a discontinuous sucrose gradient consisting of 2.5-ml 
layers of 55, 50, 45, 40 and 35% (w/w) sucrose, and 
1.8 ml of 30% (w/w) sucrose in TE buffer with 2 mM 
DTT and centrifuged in a Optima LE-80 K ultracentri-
fuge (25,000 r.p.m. for 16 h at 4°C, Beckman SW28.1 
rotor). Fractions of 1 ml were collected from the bot-
tom to the top using a peristaltic pump, and samples 
were prepared for SDS-PAGE analysis.
Results
Secretion and processing of MafBI proteins
To investigate the possible role of MafA proteins in the 
secretion of MafB proteins, we used N. meningitidis 
strain BB-1, which can potentially synthesize four 
MafB and three MafA proteins (Figure 1). First, the 
expression and localization of MafBI proteins was stu-
died. Unfortunately, an antiserum raised against an 
N-terminal fragment of the MafBI.1 protein failed to 
detect any protein bands on Western blots that could 
correspond to either one of the two MafBI proteins of 
BB-1, possibly because the production levels in the 
growth medium used were too low. Thus, we decided 
to overproduce a recombinant MafBI from a plasmid, 
for which we chose MafBI.1 encoded on MGI-1 of strain 
FAM18 (locus tag NMC1790). In contrast to the MafBI 
proteins of BB-1, this MafBI protein contains a Hint 
domain in between the DUF1020 and the C-terminal 
toxic domain (Figure 2(a) and S2). To avoid toxicity 
problems, the toxic domain of the protein was replaced 
by a Strep-tag, and the recombinant protein was desig-
nated MafBI* (Figure 2(a)). IPTG-induced production 
of MafBI* in strain BB-1 resulted in the detection of 
bands of ~54, 51 and 35 kDa with the anti-MafBI serum 
in cell lysates, presumably corresponding with the 
unprocessed precursor of the recombinant protein, the 
processed full-length protein lacking the signal 
sequence, and the DUF1020 domain alone, respectively 
(Figure 2(b), left panel). However, our Strep-tag anti-
bodies did not react with any of these bands. Therefore, 
to confirm our interpretation of the bands, the Strep- 
tag was replaced by a His10-tag. In this case, we 
detected the 54- and 51-kDa bands but not the 35- 
kDa band in cell lysates with anti-His-tag antibodies 
(Figure 2(b), right panel), confirming that the two 
larger bands contain an intact C terminus. 
Remarkably, two prominent bands of 12 and 13 kDa 
were detected in the culture medium with the anti- 
MafBI antiserum (Figure 2(b), left panel), indicating 
that MafBI is secreted and further proteolyzed into 
fragments. No bands were detected in the culture med-
ium with the anti-His-tag antibodies.
To investigate the role of MafA in the secretion 
process, the MafBI* protein was produced in various 
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Figure 2. Expression, secretion, and proteolysis of MafBI*. (a) Structure of MafBI.1 encoded by locus NMC1790 of strain FAM18. The 
protein contains a signal sequence (SS), a DUF1020 domain, a Hint domain, and a C-terminal toxic domain. The mass of each domain 
is given (in kDa). The recombinant MafBI* proteins lack the toxic domain and instead contain either a Strep-tag or, where explicitly 
indicated, a His-tag. (b) Secretion and processing of MafBI*. Proteins in cell lysates (c) and spent medium (m) of BB-1 (WT) and its 
single and double mafAI mutant derivatives (ΔAI.1 and ΔAI.2) were separated by SDS-PAGE and probed on Western blots with antisera 
directed against MafB (α-MafBI) or against the His-tag (α-His). The presence or absence in the strains of pEN-mafBI-S encoding MafBI* 
with a Strep-tag in the left panel or of pEN-mafBI-H, which encodes a His-tagged variant of MafBI*, in the right panel and of IPTG to 
induce MafBI* production, is indicated. Open arrow-heads indicate MafB forms suggested to be the precursor (p), the mature form 
after removal of the signal sequence (M), the DUF1020 domain (d), and proteolytic DUF1020 fragments (f). The filled arrow-head 
indicates a cross-reacting band. (c) The medium fractions (M) of the wild-type and the mafAI double mutant, both expressing MafBI*, 
were subjected to ultracentrifugation, and the pelleted OMVs (o) and the OMV-depleted supernatant (M−) were analyzed by SDS- 
PAGE and Western blotting. As controls, the presence in the fractions of the OM-associated periplasmic protein RmpM and the 
secreted α-peptide (αP) of IgA protease were analyzed. (d) Protease accessibility of MafBI* forms. Upper panels: Intact cells of the 
parent strain (WT) and the ΔmafAI double mutant, both synthesizing MafBI* from pEN-mafBI-S, were incubated with 2 μg ml
−1 of 
proteinase K. Lower panels: spent-medium fractions of the same cultures were treated with proteinase K. Degradation of various 
proteins was assessed by Western blotting. Different MafBI* forms are indicated at the right and labeled as in panel B. (e) The 
medium fraction of the ΔmafAI double mutant producing MafBI* was either treated or not with 1% elugent before proteinase 
K digestion.
VIRULENCE 1707
mafA mutants. Deletion of both mafAI genes (orange in 
Figure 1) individually did not affect the band pattern in 
cell lysates or spent media as compared with the wild 
type. However, deletion of both mafAI genes together 
resulted in a strong accumulation of the 51- and 35- 
kDa forms of MafBI* in the cells and a drastic reduction 
of the smaller fragments in the culture medium (Figure 
2(b), left panel). The culture medium, however, also 
contained considerable amounts of the 51- and 35- 
kDa forms of MafBI*. We considered the possibility 
that these proteins were associated with spontaneously 
released OMVs. Indeed, like the OM-associated protein 
RmpM, these proteins were pelleted from the culture 
media by ultracentrifugation (Figure 2(c), right panel). 
In contrast, the 12- and 13-kDa proteolytic fragments 
detected in the culture medium of the wild-type strain 
were not removed by ultracentrifugation (Figure 2(c), 
left panel). Similarly, the α-peptide of the autotranspor-
ter IgA protease, which is released from the bacterial 
cell surface into the culture medium by the proteolytic 
activity of another autotransporter, i.e. NalP [22], was 
found in the OMV-depleted culture supernatant 
(Figure 2(c)). Thus, the 12- and 13-kDa proteolytic 
fragments of MafB present in the culture supernatant 
of the wild-type strain are not associated with OMVs.
To further localize the MafBI* forms, we assessed 
their proteinase K accessibility in intact cells and in the 
OMVs present in the culture media. Treatment of 
intact cells with proteinase K revealed that the various 
MafBI* forms detected in cell lysates of the wild type 
and the ΔmafAI double mutant were not accessible to 
the protease (Figure 2(d), top panels), indicating that 
they are not exposed at the surface of the cells. In 
contrast, the 12- and 13-kDa MafBI* fragments in the 
culture medium of the wild type were readily degraded 
(Figure 2(d), bottom left panel) indicating that they 
were released into the culture medium, while the larger 
polypeptides associated with the OMVs of the ΔmafAI 
double mutant were inaccessible (Figure 2(d), bottom 
right panel) and only degraded after solubilization of 
the OMVs with detergent (Figure 2(e)). Therefore, 
these polypeptides are encapsulated within the OMVs. 
As a control, also the OM-associated protein RmpM, 
which has a large, periplasmically exposed peptidogly-
can-binding domain [24] was analyzed. As expected, 
this protein was only degraded after treatment of the 
medium fraction with detergent (Figure 2(e)). In con-
clusion, MafBI* is transported across the OM in wild- 
type cells, and MafAI is involved in this process. At the 
cell surface, MafBI* is proteolyzed generating 
N-terminal fragments of 12 and 13 kDa, which are 
released into the milieu. The accumulation of larger 
forms of MafBI* in wild-type cells is probably due to 
the overproduction of the protein, which cannot be 
sufficiently dealt with by the amounts of MafAI pro-
duced at wild-type level from the chromosome. It is 
noteworthy that the ΔmafAI double mutant used in the 
experiments described above still contains an intact 
mafAII gene located on MGI-3 (blue in Figure 1), 
which is apparently not used for the secretion of the 
recombinant MafBI*, thus showing specificity of the 
transporter.
To further investigate the proteolysis of MafB after 
secretion, we introduced the plasmid encoding MafBI* 
in different mutants that lack the secreted proteases 
NalP, IgA protease or App [22,25]. However, all these 
mutants showed a similar degradation pattern of MafB 
(Figure S3).
Secretion and processing of MafBIII protein
We next analyzed the synthesis and localization of 
MafBIII protein (green in Figure 1). MafBIII protein 
consists of a DUF1020 domain and a C-terminal toxic 
domain without a Hint domain in between (Figure 3(a) 
and Figure S2). MafBI of FAM18 and MafBIII of B16B6 
or FMA18 are very different; they only share 60% 
identity in a 70 amino-acid long region within the 
DUF1020 domain (Figure S2). An antiserum raised 
against an N-terminal fragment of the protein failed 
to detect a band that could correspond with MafBIII in 
cells or spent culture medium of BB-1. Thus, a plasmid 
was constructed to produce a recombinant MafBIII 
protein, designated MafBIII*, which lacks the 
C-terminal toxic domain (Figure 3(a)), and the plasmid 
was introduced into strain BB-1. Upon induction with 
IPTG, a prominent band of 20 kDa was detected in the 
spent medium with the anti-MafBIII serum on Western 
blots (Figure 3(b)). Like the secreted α-peptide of IgA 
protease and unlike the OM-associated protein RmpM, 
this band was not pelleted with the OMVs (Figure 3 
(c)), and it was sensitive to proteinase K (Figure 3(d)), 
demonstrating that it was released into the external 
medium. Unexpectedly, deletion of the mafAII gene 
located on MGI-3 (blue in Figure 1) did not affect the 
presence of the band in the medium fraction (Figure 3 
(b)), suggesting that the secretion of MafBIII might also 
be mediated by MafAI proteins (orange in Figure 1). To 
test this possibility, a triple mutant was constructed that 
lacks all mafA genes. This was done in the encapsulated 
parental strain of BB-1, i.e. strain B16B6, to have the 
availability of enough antibiotic-resistance markers for 
the gene disruptions. The abundance of the 20- kDa 
MafBIII-specific band in the medium fraction was simi-
lar in the wild-type B16B6 strain as in the unencapsu-
lated BB-1 strain (data not shown). Indeed, deletion of 
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all mafA genes resulted in a drastic reduction in the 
amounts of the 20-kDa MafBIII-specific band in the 
medium (Figure 3(b)). However, we still detected the 
presence of the MafBIII fragment in the triple mutant 
when our blot was overexposed (Figure S4). Even in 
this overexposure, no MafBIII-specific bands were 
detected in the cell lysates (Figure S4), indicating that 
MafBIII is intracellularly degraded when it is not 
secreted. Thus, MafBIII secretion can apparently be 
mediated by different MafAs. Together, these results 
indicate that MafBIII can be secreted not only by the 
MafAII encoded on the same MGI but also via the 
MafAI proteins encoded on the other MGIs. The 
minor amounts of MafBIII fragment still detectable in 
the supernatant of the triple mafA mutant may result 
from secretion via a bypass pathway or from cell lysis. 
Its presence indicates that the proteolysis generating 
this fragment is not dependent of MafA expression.
Reconstitution of MafBIII secretion in E. coli
To confirm the MafA-dependency of MafBIII secretion 
and to investigate whether MafA is sufficient for this 
process, we attempted to reconstitute MafBIII secretion 
in E. coli. Two DNA fragments, one containing the 
entire mafA, mafB and mafI genes and the other con-
taining only mafB and mafI of island MGI-3, were 
cloned into a plasmid, and MafB production and secre-
tion were assessed in E. coli strain BL21(DE3). In both 
cases, intact MafBIII was detected in whole cell lysates 
(Figure 4(a)) and not in the culture supernatants. When 
MafBIII was expressed without MafAII, the band corre-
sponding to the full-length MafBIII was of lower inten-
sity, and bands of lower apparent molecular weight, 
probably corresponding to degradation products, were 
detected. To determine the surface exposure of the 
proteins, their proteinase K accessibility in intact cells 
was assessed. MafBIII was degraded by proteinase K but 
only when it was co-expressed with MafAII (Figure 4 
(b)). The OM protein OmpA, which has a large 
C-terminal periplasmic domain, was not degraded by 
proteinase K showing the integrity of the OM. Thus, 
these data confirm that MafA mediates the transport of 
MafBIII to the bacterial cell surface and that no other 
specific protein from N. meningitidis is required for this 
secretion process.
Expression and localization of MafA proteins
To mediate the secretion of MafB, MafA should be 
localized in the OM. To confirm its subcellular locali-
zation and study its membrane topology, antisera were 
raised against MafAI.1 and MafAII proteins of BB-1. 
Both mature MafAI proteins (orange in Figure 1) differ 
in only two amino-acid residues (Figure S1b) and, 
therefore, cross-reactivity is to be expected. They 
share 61% of sequence identity with MafAII (blue in 
Figure 1; Figure S1b). Two bands with apparent 
Figure 3. Expression, secretion, and proteolysis of MafBIII. (a) 
Structure of MafBIII encoded on MGI-3 of strain B16B6. The 
protein contains a signal sequence (SS), a DUF1020 domain, 
and a C-terminal toxic domain. The mass of each domain is 
given (in kDa). The truncated MafBIII* protein lacks the toxic 
domain and instead contains a Strep-tag. (b) Expression and 
localization of MafBIII* in N. meningitidis. Proteins in cell lysates 
(c) and spent medium (m) of the unencapsulated strain BB-1 
(WTc-), its derivative lacking mafAII (ΔAII), and a derivative of the 
encapsulated parental strain B16B6 (c+) lacking all mafA genes 
(ΔAI.1ΔAI.2ΔAII) were separated by SDS-PAGE and probed on 
Western blots with antiserum directed against MafBIII. The pre-
sence of plasmid pEN-mafBIII-S in the strains and of IPTG during 
growth is indicated. (c) The medium fraction (M) of strain BB-1 
expressing MafBIII* was subjected to ultracentrifugation, and 
the pellet containing OMVs (o) and the OMV-depleted super-
natant (M−) were analyzed by SDS-PAGE and Western blotting. 
As controls, the presence in the fractions of the OM-associated 
protein RmpM and the secreted α-peptide (αP) of IgA protease 
was analyzed. (d) Culture medium from strain BB-1 expressing 
MafBIII* was treated with 2 μg ml
−1 proteinase K, and degrada-
tion of MafBIII* and, as a control, of the OM-associated periplas-
mic protein RmpM, was assessed by Western blotting. In panels 
b-d, F indicates proteolytic fragments of MafBIII.
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molecular weights of ~34 kDa, corresponding with the 
expected mass of MafA proteins, were detected on 
Western blots with the anti-MafAI serum in whole 
cell lysates of the parental strain (Figure 5(a), left 
panel). The upper and most prominent band was not 
present in the lysates of the ΔmafAI.1 mutant and thus 
corresponds with MafAI.1, whilst the lower and fainter 
band was not detected in the ΔmafAI.2 mutant (Figure 5 
(a), left panel). The anti-MafAII antiserum detected 
only one band of approximately 34 kDa in whole cell 
lysates of BB-1, and this band was absent in the 
ΔmafAII mutant (Figure 5(a), right panel). No MafA- 
related bands were detected in the spent culture media 
(Figure 5(a)).
Upon cell fractionation, the MafA proteins were 
detected in the cell envelope fraction (shown for 
MafAI.1 in Figure S5). To localize them more precisely, 
the OM and IM were separated by sucrose density 
gradient centrifugation. Since the antibodies hardly 
detected the proteins in the separate fractions, recom-
binant His6-tagged MafAI.1 and MafAII were used in 
these experiments. MafAI.1 co-fractionated with the 
OM-associated marker protein RmpM and clearly dif-
ferent from the DsbA lipoproteins, which are two IM- 
associated lipoproteins in N. meningitidis [21] (Figure 5 
(b)). To test whether the protein is surface exposed, its 
proteinase K accessibility was assessed. For these 
experiments, we used a nalP mutant of strain BB-1. In 
this strain, the α-peptide of IgA protease remains pre-
sent at the cell surface associated with the translocator 
domain of the autotransporter [22], allowing its use as 
a protease-accessible positive control. In contrast to the 
α-peptide, MafAI.1, MafAI.2 and MafAII were not 
affected by treatment of intact bacteria with proteinase 
K (shown for the MafAI proteins in Figure 5(c), left 
panel). However, similar as the periplasmically exposed 
OM-associated protein RmpM, MafA was partially 
degraded by treatment of cell envelopes with proteinase 
K and completely when the cell envelopes were first 
solubilized in detergent before protease treatment 
(Figure 5(c), right panels). Together, these results 
demonstrate that MafA is located in the OM and 
accessible for proteases from the periplasmic side, but 
it does not expose large protease-accessible loops at the 
cell surface.
MafA is not predicted to form a β-barrel structure as 
typical OM proteins do (Figure S1a). Thus, we asked 
how MafA could be integrated in the OM to be able to 
function as a transporter. Some transporters for macro-
molecules in the OM, such as the capsular polysacchar-
ide transporter Wza [26] or the VirB10 component of 
the type IV secretion system [27], form multimers with 
each monomer inserted into the OM only with a small 
segment of the polypeptide, and together, these small 
segments are forming a central channel. To investigate 
the possibility that also MafA forms multimers, cell 
envelope preparations were analyzed by SDS-PAGE 
either with or without heat denaturation of the samples 
before electrophoresis. The anti-MafAI serum did 
neither detect monomeric nor multimeric forms of 
MafAI in non-heated samples, suggesting that the epi-
topes are masked when the protein is in its native 
conformation. Therefore, the His-tagged MafAI was 
employed again. A band of 34 kDa corresponding 
with monomeric MafAI was detected in the heated 
samples, whilst a band migrating at an apparent mole-
cular weight of ~270 kDa was revealed with antibodies 
against the His tag when the samples were not dena-
tured before electrophoresis (Figure 5(d)). A similar 
heat modifiability was detected when MafAII was ana-
lyzed (Figure 5(d)); in this case, the anti-MafAII anti-
serum detected the complex. These results indicate that 
the MafA proteins form oligomeric complexes. The 
complexes were also detected when only MafAI or only 
MafAII was overexpressed from plasmid in the triple 
ΔmafA mutant (results not shown), suggesting the pro-
teins form independent complexes. Purification of the 
MafAII complex from Coomassie-stained gels and sub-
sequent MALDI-TOF mass spectrometry analysis 
revealed that the complex was constituted only of 
Figure 4. Expression and localization of MafBIII in E. coli. (a) 
MafBIII and the corresponding MafI were produced in BL21(DE3) 
either with (BL21-AII+BIII+I) or without (BL21-BIII+I) MafAII, and 
cell lysates were analyzed by Western blotting with antiserum 
against MafBIII. The blot at the right was exposed longer than 
the one at the left to obtain visible MafB-specific signals. (b) 
Intact cells of both BL21(DE3) derivatives were incubated with 
the indicated concentrations of proteinase K and degradation of 
MafBIII, and, as a control, of OmpA, a β-barrel OM protein with 
a large periplasmic domain, was assessed by Western blotting. 
In both panels, M indicates the full-length mature form of 
MafBIII, and F in panel A indicates proteolytic fragments of 
the protein. The filled arrow-head in panel A indicates 
a background band.
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MafA protein (Table S2). Together, these results 
demonstrate that MafA is located in the OM and that 
it forms a homo-oligomeric complex.
Dissemination of Maf systems among 
Gram-negative bacteria
So far, MafA and MafB proteins have only been 
reported to be present in Neisseria spp. and to be 
particularly abundant among the pathogenic Neisseria 
Figure 5. Synthesis and subcellular localization of MafA. (a) The synthesis and possible secretion of MafA proteins were examined by 
analyzing cell lysates (c) and spent media (m) of BB-1 (WT) and various ΔmafA mutant derivatives on Western blots with anti-MafA 
antisera. The positions of MafA proteins are indicated with open arrowheads. A faint cross-reactive band with a similar electro-
phoretic mobility is visible in the mafAI.1 mutant and the double mutant and is indicated with a black arrowhead. (b) Membranes of 
BB-1 synthesizing a His-tagged recombinant MafAI protein from plasmid pEN-mafAI-H were separated by sucrose density gradient 
centrifugation, and the fractions obtained were analyzed by Western blotting with antibodies directed against the His-tag, against 
RmpM as an OM marker, and against DsbA as IM markers. (c) Intact cells or cell envelopes of BB-1ΔnalP expressing His-tagged MafAI 
were treated with 2 μg ml−1 proteinase K as indicated. Cell envelopes were treated or not with 1% elugent before proteinase 
K digestion. After incubation, the degradation of MafAI, RmpM and the α-peptide (αP) of IgA protease were assessed by Western 
blotting using specific antibodies. The αP is exposed at the cell surface covalently connected to the translocator domain (TD) of IgA 
protease [22]. For this blot, an antiserum directed against the TD was used. (d) Western blot analysis of cell envelopes from strain BB- 
1 synthesizing or not His-tagged MafAI from plasmid pEN-mafAI-H and MafAII from the chromosome. The blots were probed with 
anti-His-tag antibodies and anti-MafAII antiserum, respectively. Before electrophoresis, proteins were either denatured or not by 
heating the samples at 95°C. HMW complex indicates the position of the high-molecular-weight complexes of the MafA proteins 
detected in the unheated samples. Filled arrowheads mark weak cross-reactive bands. Numbers at the left indicate the positions of 
molecular mass markers when required. In panels b and c, only relevant parts of the blots are shown.
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[10,11]. We performed new BLAST searches and found 
that the Maf systems are actually much more widely 
disseminated among Gram-negative bacteria. For 
example, when using MafAII as a query in protein 
BLASTs, we identified homologs also in other genera 
of the Neisseriaceae, such as the proteins encoded by 
the genes with locus tags CX403_RS04975 from 
Bergeriella denitrificans isolate R981, which shows 
99.4% sequence identity, or NCTC13336_01484 from 
Kingella potus strain NCTC13336, which shows 94.1% 
sequence identity. However, homologs were also 
detected in species from the γ subdivision of 
Proteobacteria, such as the proteins encoded by the 
genes with locus tags A9Z60_03095 in Moraxella non-
liquefaciens strain CCUG60284 (59% identity; E-value 
4e−126) or BECKTC1821D_GA0114238_101426 in 
Candidatus Kentron sp. TC isolate BECK_BZ123 (49% 
identity; E-value 1e−83). In all these isolates, the mafA 
gene was flanked by a mafB gene, characterized by the 
DUF1020. Homologs were also detected in the δ- 
proteobacteria, such as the protein encoded by the 
gene with locus tag Q362_RS19135 from 
Desulfobulbus elongatus strain DSM2908 (E-value 
6e−76) and even in the Planctomycetes, such as the 
protein with Seq. ID HBG28899.1 from 
Phycisphaerales bacterium DDX75_17575 (E-value 
2e−17). However, in these latter cases, the mafA homo-
log is not flanked by a mafB homolog; hence, it is not 
clear whether in these cases the MafA homolog is 
involved in secretion or, perhaps, only functions as an 
adhesin. A full account of the dissemination of Maf 
homologs will be presented elsewhere.
Discussion
Recently, we and others showed that MafB is a toxin 
involved in interbacterial competition [10,11]. Jamet 
et al. (2015) concluded that MafB is secreted [11], as 
judged from the detection of a full-length form of the 
MafBI protein in the spent culture medium, but they 
failed to find evidence for an involvement of MafA in 
the secretion mechanism, i.e. MafBI was also detected 
in the culture medium when it was heterologously 
expressed in a Neisseria cinerea strain lacking any 
mafA. They proposed that MafB could be released 
into the medium in OMVs. However, they did not 
test this possibility, nor did they investigate whether 
MafB was included inside or exposed on the surface of 
such OMVs. In our experiments, various MafBI forms, 
corresponding to the mature protein and the separate 
DUF1020, were present in the culture medium of 
a mafA mutant, where they were found to be associated 
with OMVs. Protease-accessibility experiments showed 
that these polypeptides are localized inside the OMVs, 
and we hypothesize that this was also the case for the 
MafBI detected in the culture medium of mafA- 
deficient N. cinerea by Jamet et al. [11]. Only when 
MafA was expressed, we detected smaller MafB frag-
ments in the culture medium, which, considering their 
reactivity with the antiserum used, corresponded with 
the N-terminal part of the DUF1020 domain. These 
smaller fragments were not associated with OMVs, 
and they were not detected by Jamet et al. [11], prob-
ably because the authors used antibodies against 
a C-terminal FLAG tag and against a C-terminal 
MafB peptide.
Reconstitution of the secretion process in E. coli 
unequivocally confirmed the MafA-dependency of 
MafB translocation across the OM. When produced in 
the absence of MafA, MafBIII was found in the cell 
lysates and not in the spent medium, consistent with 
results presented by Jamet et al. [11]. Protease- 
accessibility assays showed that the protein was not 
exposed on the cell surface in this case. When MafAII 
was co-expressed, MafBIII was still found in the cell 
lysates, but it was protease accessible, hence transported 
to the cell surface. This result also demonstrates that 
MafA is the only neisserial protein required for the 
secretion of MafB, although we cannot exclude the 
possibility that a commonly present OM protein, such 
as BamA, is also involved in the secretion process.
Our model for secretion and processing of MafB is 
presented in Figure 6. MafB proteins are produced with 
an N-terminal signal sequence followed by a DUF1020 
domain, which are both required for the secretion 
process. The N-terminal signal sequence marks them 
for transport across the inner membrane to the peri-
plasm probably via the Sec system [11]. In the peri-
plasm, presumably protein chaperones prevent folding 
of MafB [3]. Then, MafB interacts via the DUF1020 
domain with the OM-inserted MafA complex, which 
mediates its transport through the OM. Our results 
evidence the coexistence of at least two independent 
MafA/B secretion systems. MafAII exclusively mediates 
the secretion of MafBIII, which is encoded on the same 
MGI-3 (Figure 1). In contrast, MafAI allows for the 
secretion of both MafBI and MafBIII. Possibly, MafAI 
is also involved in the secretion of MafBII. The gene for 
MafBII is not immediately adjacent to a mafA gene, but 
there is a MafAI encoded on the same MGI (Figure 1), 
and the DUF1020 domain of MafBII is more related to 
that of MafBI than to that of MafBIII [10]. Similar 
features were described in meningococcal TPS systems, 
where the TpsB1 transporter is very specific and recog-
nizes exclusively the cognate TpsA substrates, whilst 
TpsB2 can transport all available TpsA substrates 
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[28,29]. Like TpsA proteins that function in growth 
inhibition [5], surface-exposed MafB probably interacts 
with a receptor on a target cell, after which the 
C-terminal toxic domain is cleaved and imported into 
the target cell. Cleavage probably takes place within the 
DUF1020 domain, and the N-terminal fragments are 
released into the medium. The proteolytic enzyme that 
cleaves MafB is not known. Probably, cleavage is an 
autocatalytic process that is induced by conformational 
changes in the protein upon receptor interaction, but 
some MafB proteins also contain a classical Hint 
domain (i.e. MafBI), which may facilitate the release 
of the C-terminal toxic domain to the medium. Cell- 
surface-exposed MafBIII was not cleaved in E. coli, pre-
sumably because E. coli cells do not express the appro-
priate receptor.
To function as a transporter for MafB, MafA should 
be incorporated into the OM. Indeed, we showed that 
MafA is localized in the OM as an oligomer. 
Considering the size of the monomer (34 kDa) and 
the apparent molecular weight of the oligomer (270 
kDa), MafA could form a complex constituted of 
approximately eight subunits. MafA proteins are sup-
posedly lipoproteins and have both α-helical and β- 
sheet content according to secondary structure predic-
tion (Figure S1a), which is atypical for integral OM 
proteins. These properties are reminiscent of those of 
CsgG, an OM protein that transports amyloids, known 
as Curli, to the cell surface [30,31]. Also, CsgG is 
a lipoprotein with a mixed α-helical and β-sheet con-
tent. Its native structure is a 36-stranded β-barrel 
composed of nine subunits, where each subunit con-
tributes four β-strands to the barrel, while the α-helices 
extend into the periplasm [30,31]. Possibly, MafA 
forms a similar structure. Alternatively, it may be 
embedded in the OM like the capsular polysaccharide 
transporter Wza, which also is a lipoprotein [26], and 
the VirB10 component of type IV secretion system 
[27]. The transmembrane segments of these oligomeric 
OM proteins are amphipathic α-helices instead of 
amphipathic β-strands as found in classical OM pro-
teins. However, helical wheel projections did not indi-
cate that the α-helices in MafA are amphipathic 
(Figure S1a).
Over the last decade, various contact-dependent 
growth-inhibition systems have been identified and 
characterized [32]. These systems are broadly distribu-
ted among bacterial species. In general, the toxins pro-
duced in these systems are delivered to the target cell 
utilizing the TPS [5] or Type VI protein secretion 
system [33]. Both systems can also deliver the toxin 
into mammalian cells contributing to virulence of 
pathogens [34,35]. The MafB proteins were recently 
discovered as a new family of toxic proteins in 
Neisseria spp [10,11]. Here, we demonstrated that 
Figure 6. Proposed model for MafB secretion and activation. 
The MafB proteins contain a cleavable N-terminal signal 
sequence (yellow) for translocation across the inner membrane 
(IM) via the Sec translocon. After periplasmic transit, possibly 
escorted by chaperones like SurA or Skp (purple), MafB interacts 
with the OM-integrated MafA protein, presumably through its 
DUF1020 domain. The oligomeric MafA protein constitutes the 
channel in the OM through which MafB is translocated. After 
secretion, MafB presumably remains associated with the OM 
until it interacts with a receptor at the target cell. Then, MafB is 
cleaved by an unknown protease or via an autocatalytic process 
that is induced by conformational changes in the protein upon 
receptor interaction. The C-terminal domain of MafB is thereby 
released and imported into the target cell where it exerts its 
toxic activity.
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these proteins are transported across the bacterial OM 
employing the MafA proteins. Superficially, the MafA/ 
B systems may look similar to the TPS systems in that 
a single OM protein is required for the secretion of 
a toxic module, which is secreted as a part of a larger 
protein. However, the differences between the systems 
are large. First, unlike the TpsB proteins, MafA is not 
an Omp85-family member as it lacks the characteristic 
POTRA and β-barrel domains. Also, whilst the TpsB 
proteins function as monomers, MafA proteins form 
large oligomers. Second, whilst the toxic modules of 
TpsA and MafB proteins are similar, the rest of these 
proteins is very different. The TpsA proteins are large 
filamentous proteins with a β-helical structure present-
ing typical hemagglutinin repeats and, at the 
N terminus, a TPS domain required for recognition 
by the POTRA domains of TpsB [2,29]. All those char-
acteristics are missing in the MafB proteins, which are 
much smaller and contain a characteristic DUF1020 
domain, which is presumably required for recognition 
by MafA. Thus, the MafA/B system represents a novel 
secretion system. Interestingly, whereas this system 
had, so far, only been reported in Neisseria spp., we 
detected homologs now also in other bacterial species. 
As it has been demonstrated that MafA contributes to 
the pathogenicity of Neisseria spp [14–16]., it will be 
interesting now to investigate whether the MafA/B sys-
tem also contributes to the virulence of the pathogenic 
Neisseria by delivering MafB toxins into host cells as 
described for other CDI systems [35].
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